
Andrii Dodonov
- Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) extended three days of gains on Tuesday after the company announced that its board of directors has authorized a new share buyback program worth up to $4B.
- Under the program, the cystic fibrosis drugmaker is set